The exploratory study on change of the gutmicrobiota in Rabeprazole divided doses:Direction crossover controlled trial in front of an open label
Not Applicable
- Conditions
- Reflux esophagitis.
- Registration Number
- JPRN-UMIN000032040
- Lead Sponsor
- Shiga University of Medical Science
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 12
Inclusion Criteria
Not provided
Exclusion Criteria
1.No consent 2.With the drug including a suppressant acid-secreting for the past one month. 3.With probiotics (medicine for intestinal disorders) or the antimicrobial agent for the past one month. 4.With grapefruits for the past two weeks. 5.With operating treatment for upper gastrointestinal disease including esophagus and stomach. 6.During pregnancy or nursing.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Correlation of intragastric pH and enteric bacteria profile.
- Secondary Outcome Measures
Name Time Method